NCT04941794 Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes
| NCT ID | NCT04941794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Regionshospital Nordjylland |
| Condition | Type 2 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-07-01 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-07-01 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A cohort study on patients with type 2 diabetes to investigate possible biomarkers as predictors of chronic heart failure.
Eligibility Criteria
Inclusion Criteria: * Type 2 diabetes * age \> 50 years Exclusion Criteria: * History of acute or chronic heart failure * History of ischemic heart disease
Contact & Investigator
Steen Hylgaard Jørgensen, MD
PRINCIPAL INVESTIGATOR
Department of Cardiology
Frequently Asked Questions
Who can join the NCT04941794 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04941794 currently recruiting?
Yes, NCT04941794 is actively recruiting participants. Contact the research team at p.leutscher@rn.dk for enrollment information.
Where is the NCT04941794 trial being conducted?
This trial is being conducted at Hjørring, Denmark.
Who is sponsoring the NCT04941794 clinical trial?
NCT04941794 is sponsored by Regionshospital Nordjylland. The principal investigator is Steen Hylgaard Jørgensen, MD at Department of Cardiology. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.